PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$168,000
+23.5%
4,414
-18.5%
0.00%0.0%
Q3 2022$136,000
-90.2%
5,416
-61.0%
0.00%
-80.0%
Q1 2021$1,385,000
-5.1%
13,888
+17.6%
0.01%
-28.6%
Q4 2020$1,460,000
+40.7%
11,810
+10.9%
0.01%
+16.7%
Q3 2020$1,038,000
-26.4%
10,654
+17.9%
0.01%
-25.0%
Q2 2020$1,410,0009,0400.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders